Cognitive Therapies Ltd - Accounts to registrar (filleted) - small 22.3

Cognitive Therapies Ltd - Accounts to registrar (filleted) - small 22.3


IRIS Accounts Production v22.3.3.48 06801683 director 1.2.21 31.1.22 31.1.22 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure068016832021-01-31068016832022-01-31068016832021-02-012022-01-31068016832020-01-31068016832020-02-012021-01-31068016832021-01-3106801683ns16:EnglandWales2021-02-012022-01-3106801683ns15:PoundSterling2021-02-012022-01-3106801683ns11:Director12021-02-012022-01-3106801683ns11:PrivateLimitedCompanyLtd2021-02-012022-01-3106801683ns11:SmallEntities2021-02-012022-01-3106801683ns11:AuditExempt-NoAccountantsReport2021-02-012022-01-3106801683ns11:SmallCompaniesRegimeForDirectorsReport2021-02-012022-01-3106801683ns11:SmallCompaniesRegimeForAccounts2021-02-012022-01-3106801683ns11:FullAccounts2021-02-012022-01-3106801683ns11:OrdinaryShareClass12021-02-012022-01-3106801683ns11:RegisteredOffice2021-02-012022-01-3106801683ns6:CurrentFinancialInstruments2022-01-3106801683ns6:CurrentFinancialInstruments2021-01-3106801683ns6:ShareCapital2022-01-3106801683ns6:ShareCapital2021-01-3106801683ns6:RetainedEarningsAccumulatedLosses2022-01-3106801683ns6:RetainedEarningsAccumulatedLosses2021-01-3106801683ns6:FurnitureFittings2021-02-012022-01-3106801683ns6:FurnitureFittings2021-01-3106801683ns6:ComputerEquipment2021-01-3106801683ns6:ComputerEquipment2021-02-012022-01-3106801683ns6:FurnitureFittings2022-01-3106801683ns6:ComputerEquipment2022-01-3106801683ns6:FurnitureFittings2021-01-3106801683ns6:ComputerEquipment2021-01-3106801683ns6:DeferredTaxation2021-01-3106801683ns6:DeferredTaxation2021-02-012022-01-3106801683ns6:DeferredTaxation2022-01-3106801683ns11:OrdinaryShareClass12022-01-31
REGISTERED NUMBER: 06801683 (England and Wales)













Unaudited Financial Statements

for the Year Ended 31 January 2022

for

COGNITIVE THERAPIES LTD

COGNITIVE THERAPIES LTD (REGISTERED NUMBER: 06801683)






Contents of the Financial Statements
FOR THE YEAR ENDED 31 JANUARY 2022




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


COGNITIVE THERAPIES LTD

Company Information
FOR THE YEAR ENDED 31 JANUARY 2022







Director: Mr D Brough





Registered office: Mind Healthcare, Suite 3
Second Floor Elizabeth House
Southgate
Wigan
Lancashire
WN3 4EX





Registered number: 06801683 (England and Wales)





Accountants: NRB
1st Floor Waterside House
Waterside Drive
Wigan
Lancashire
WN3 5AZ

COGNITIVE THERAPIES LTD (REGISTERED NUMBER: 06801683)

Balance Sheet
31 JANUARY 2022

31.1.22 31.1.21
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 3,894 4,363

CURRENT ASSETS
Cash at bank 10,334 21,282

CREDITORS
Amounts falling due within one year 5 13,083 26,413
NET CURRENT LIABILITIES (2,749 ) (5,131 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,145

(768

)

PROVISIONS FOR LIABILITIES 6 740 370
NET ASSETS/(LIABILITIES) 405 (1,138 )

CAPITAL AND RESERVES
Called up share capital 7 10 10
Retained earnings 395 (1,148 )
SHAREHOLDERS' FUNDS 405 (1,138 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2022.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2022 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 22 March 2023 and were signed by:





Mr D Brough - Director


COGNITIVE THERAPIES LTD (REGISTERED NUMBER: 06801683)

Notes to the Financial Statements
FOR THE YEAR ENDED 31 JANUARY 2022

1. STATUTORY INFORMATION

Cognitive Therapies Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 25% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2021 - 2 ) .

COGNITIVE THERAPIES LTD (REGISTERED NUMBER: 06801683)

Notes to the Financial Statements - continued
FOR THE YEAR ENDED 31 JANUARY 2022

4. TANGIBLE FIXED ASSETS
Fixtures
and Computer
fittings equipment Totals
£    £    £   
COST
At 1 February 2021 6,968 2,211 9,179
Additions - 828 828
At 31 January 2022 6,968 3,039 10,007
DEPRECIATION
At 1 February 2021 4,263 553 4,816
Charge for year 676 621 1,297
At 31 January 2022 4,939 1,174 6,113
NET BOOK VALUE
At 31 January 2022 2,029 1,865 3,894
At 31 January 2021 2,705 1,658 4,363

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.1.22 31.1.21
£    £   
Trade creditors - (1 )
Taxation and social security 7,718 3,518
Other creditors 5,365 22,896
13,083 26,413

6. PROVISIONS FOR LIABILITIES
31.1.22 31.1.21
£    £   
Deferred tax 740 370

Deferred
tax
£   
Balance at 1 February 2021 370
Charge to Statement of Income and Retained Earnings during year 370
Balance at 31 January 2022 740

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.1.22 31.1.21
value: £    £   
10 Ordinary £1 10 10

8. ULTIMATE CONTROLLING PARTY

The controlling party is Mr D Brough.